Author:
Lears K A,Parry J J,Andrews R,Nguyen K,Wadas T J,Rogers B E
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Reference47 articles.
1. Doloff JC, Waxman DJ . Adenoviral vectors for prodrug activation-based gene therapy for cancer. Anticancer Agents Med Chem 2014; 14: 115–126.
2. Lawrence TS, Rehemtulla A, Ng EY, Wilson M, Trosko JE, Stetson PL . Preferential cytotoxicity of cells transduced with cytosine deaminase compared to bystander cells after treatment with 5-flucytosine. Cancer Res 1998; 58: 2588–2593.
3. Trinh QT, Austin EA, Murray DM, Knick VC, Huber BE . Enzyme/prodrug gene therapy: Comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line. Cancer Res 1995; 55: 4808–4812.
4. Goblirsch M, Zwolak P, Ramnaraine ML, Pan W, Lynch C, Alaei P et al. Novel cytosine deaminase fusion gene enhances the effect of radiation on breast cancer in bone by reducing tumor burden, osteolysis, and skeletal fracture. Clin Cancer Res 2006; 12: 3168–3176.
5. Kaliberov SA, Markert JM, Gillespie GY, Krendelchtchikova V, Della Manna D, Sellers JC et al. Mutation of Escherichia coli cytosine deaminase significantly enhances molecular chemotherapy of human glioma. Gene Ther 2007; 14: 1111–1119.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献